Screener
AnaptysBio, Inc. ANAB Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
| Line item | March 31, 2026(unaudited) | December 31, 2025 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $248,469 | $238,196 |
| Receivables from collaborative partners | 25,747 | 33,850 |
| Short-term investments | 37,986 | 73,442 |
| Prepaid expenses and other current assets | 3,907 | 4,762 |
| Total current assets | 316,109 | 350,250 |
| Property and equipment, net | 1,280 | 1,370 |
| Operating lease right-of-use assets | 12,039 | 12,519 |
Item 1. Consolidated Financial Statements
FAQ
- What is AnaptysBio, Inc.'s short-term investments?
- AnaptysBio, Inc. (ANAB) reported short-term investments of $37.99M in Q1 2026.
- How has AnaptysBio, Inc.'s short-term investments changed year-over-year?
- AnaptysBio, Inc.'s short-term investments decreased by 84.3% year-over-year, from $241.3M to $37.99M.
- What is the long-term trend for AnaptysBio, Inc.'s short-term investments?
- Over 5 years (2020 to 2025), AnaptysBio, Inc.'s short-term investments has grown at a -12.5% compound annual growth rate (CAGR), from $143.2M to $73.44M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about AnaptysBio, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude